This month’s newsletter explores the pandemic’s effects on autism rates, trends in co-occurring mental health conditions, and the impact of intranasal oxytocin.

The study, which investigated a microRNA’s links to autism, appears to contain duplicated and fabricated data, according to research integrity analysts. Those issues reflect a larger problem in the literature.

A new approach for delivering gene therapy to the brain reduces nerve damage in primates and could help make gene therapies for conditions related to autism safer.

A saliva test that helps clinicians diagnose autism is expected to be available in the next few weeks. But some experts are skeptical of the test’s accuracy and value.

Injecting a virus toting snippets of RNA into the rodent brain enables researchers to express genes in specific neuron types.

Neurons from people with autism may have an unusual pattern of chemical tags that turn genes on and off.

RNA segments that control when and where genes are expressed may be involved in autism.

The brains of people with autism contain unusual amounts of short regulatory RNAs.

Scientists are excluding U.K. colleagues from studies; a life sciences publisher abandons the ‘impact factor;’ and a new open-access journal makes its debut.

The fight over who holds the rights to CRISPR is heating up, we control our gut bacteria, and romance isn’t always easy when you have autism.